An IPO Is Not the Finish Line for Drug Discovery Biotech: Expert Summit on Sustainable Growth Set for August 22

The Backdrop of the Event

The Japan Pharmaceutical & BioScience Society (Japan PBSS) has announced that it will host "Bench to Bell, and Beyond: Financing Drug Discovery Startups—From Inception to IPO and Sustainable Growth" on Saturday, August 22, 2026, at the Nihonbashi Life Science Hub. This event serves as Volume 2 of the organization's Drug Discovery Ecosystem series.

Purpose of the Event

The summit addresses the critical challenges faced by Japanese drug discovery biotechs, particularly the so-called "100-yen wall"—a stagnation point often encountered around the time of an IPO—as well as the complexities of investor structures needed to support long-term growth. By bringing together investors, entrepreneurs, and industry experts from Japan and abroad, the event aims to reframe the IPO not as a final goal, but as a gateway to the next stage of development, offering actionable insights for sustainable expansion.

Event Details and Registration

The event will take place on Saturday, August 22, 2026, from 10:00 to 17:00. It will be held in a hybrid format, allowing for both in-person attendance at the Nihonbashi Life Science Hub and online participation. Pre-registration is required, and full details are available via the link below.

Registration Page